Search for: "Adidas AG v. Nike, Inc."
Results 1 - 18
of 18
Sorted by Relevance
|
Sort by Date
28 Jun 2020, 9:03 pm
By Joshua Rich -- Although the Federal Circuit faced obviousness issues that were simple to resolve in Adidas AG v. [read post]
13 Apr 2020, 9:59 pm
Most recently, the question before the Federal Circuit in Nike, Inc. v. [read post]
1 Sep 2022, 8:12 am
Nike, Inc. v. [read post]
11 Feb 2016, 12:12 pm
Fresenius USA, Inc. v. [read post]
11 Apr 2020, 12:34 am
§ 103.Specifically, Nike asserts that the Board violated the noticeprovisions of the APA by finding that a limitation of substitute claim 49 was well-known in the art based on a priorart reference that, while in the record, was never cited byadidas AG (“Adidas”) for disclosing that limitation. [read post]
29 Feb 2016, 1:21 pm
Recently, the United States Court of Appeals for the Federal Circuit issued a decision in Nike, Inc. v. [read post]
22 Feb 2021, 12:19 pm
Nike, Inc., No. 20-728 (are PTAB judges principal officers?) [read post]
5 Oct 2017, 3:27 pm
Cir. 2016);and Nike, Inc. v. [read post]
25 May 2016, 3:41 pm
In Nike, Inc. v. [read post]
24 Oct 2018, 9:16 am
The blaze marks analysisis a useful guide for evaluating laundry-list disclosures,like the one in Forward’s ’871 application. (...)Recently in Nike, Inc. v. [read post]
10 Nov 2021, 2:30 pm
’” See Adidas AG v. [read post]
18 Jan 2024, 9:26 am
” Nike, Inc. v. [read post]
4 Dec 2021, 8:13 am
” Adidas AG v. [read post]
15 Oct 2019, 12:31 pm
Iancu, 138 S.Ct. 1348 (2018) (all claims challenged) as expanded by Adidas AG v. [read post]
18 Sep 2018, 7:33 pm
In Adidas AG v. [read post]
7 Apr 2016, 2:27 pm
” Anderson v.Cryovac, Inc., 862 F.2d 910, 923 (1st Cir. 1988) (emphasisadded); see also Bros Inc. v. [read post]
18 Apr 2008, 2:00 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Ranbaxy and AstraZeneca reach agreement in Esomeprazole patent litigation: (SmartBrief), (IPBiz), (Spicy IP), (Profitability through Simplicity), (IP Law360), (Philip Brooks), (GenericsWeb), Cadbury loses Australian battle over exclusive use of colour purple for chocolate wrapping in its case against Darrell Lea: (Australian Trade Marks Law… [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
